期刊文献+

胰腺癌组织微血管密度及淋巴管密度的改变及临床意义 被引量:1

Clinical signigicances of measuredvalue of microvessel density and lymphatic vessel density in pancreatic carcinoma tissue
下载PDF
导出
摘要 目的:研究胰腺癌组织中微血管密度(MVD)和淋巴管密度(LVD)的变化、与胰腺癌临床病理的联系及相互关系。方法:采用免疫组织化学SABC法应用CD34检测41例胰腺导管腺癌患者配对癌组织和正常胰腺组织中MVD的表达情况,应用D2-40检测配对癌组织、癌旁组织及正常胰腺组织中LVD的表达情况,分析MVD和LVD与肿瘤分化程度、分期和淋巴转移间的相关性以及癌组织MVD与癌旁组织LVD表达之间的关系。结果:癌组织及正常胰腺组织MVD分别为46.585±16.935和11.100±4.036,两组差异有统计学意义(P=0.000)。癌组织、癌旁及正常胰腺组织LVD分别为11.244±4.800、15.829±7.470和13.512±5.139;其中癌旁组织与正常胰腺组织LVD差异无统计学意义(P=0.060),癌旁组织与癌组织的LVD差异有统计学意义(P=0.000)。胰腺癌组织MVD与癌旁组织LVD间存在相关性(P=0.025<0.05)。结论:胰腺导管腺癌组织中MVD及LVD与肿瘤分化程度、病理分期及淋巴转移相关;胰腺癌组织内MVD与癌旁组织LVD间存在相关性。 Objective: To study the changes of the microvessel density (MVD) and Lymphatic vessel density (LVD) and the relationship with the clinical pathology parameer and their interaction. Methods: The MVD and LVD were detected by using CD34 and monoclonal antibody D2-40 in 41 patients with pancreatic ductal adenocarcinoma by using immunohistochemical method SABC. The expression of MVD and LVD in the cancer, paraneoptastic and normal pancreatic tissue were analyzed relationship with the clinical pathology parameter like as the pathological stage, tumor differentiation and lymph node metastasis, and the correlation between the MVD of cancer tissues and LVD of paraneoplastic. Result: The mean MVD value in paired cancer and normal pancreatic tissue were 46.585 ± 16.935,11,100 ± 4.036 respectively. The statistically significant difference was found between the two groups (P=0.000 〈 0.01). The mean MVD value in paired cancer and normal pancreatic tissue were 46.585 ± 16.935,11.100 ± 4.036 respectively. The statistically significant difference was found between the two groups(P=0.000 〈 0.01 ).The average LVD of cancer, paraneoplastic and normal pancreatic tissue were 11,244±4.800, 15.829 ±7.470 and 13.512±5.139 respectively in 41 cases, in which significant differerce was found between the paraneoplastic and cancer tissue (P=0. 000 〈 0.01) and contrary between paraneoplastic and normal pancreatic tissue (P=0.060).Correlation was found between the MVD values of tissues and the LVD values of paraneoplastic tissues (P=0. 025 〈 0.05). Conclusion: The MVD values and LVD values of pancreatic ductal adenocarcinoma were associated with the tumor differentiation, pathological stage and lymph node metastasis. The MVD values of pancreatic cancer tissues was correlated with the LVD values of paraneoplastic tissues.
出处 《中国现代普通外科进展》 CAS 2011年第10期779-783,共5页 Chinese Journal of Current Advances in General Surgery
关键词 胰腺肿瘤 微血管密度 淋巴管密度 Carcinoma, pancreatic ductal. Microvessel density Lymphatic vessel density
  • 相关文献

参考文献22

  • 1Yeo C J, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lym- phademectomy for periampullary adenocarcinoma, part 2: random- ized controllde trial evaluating survival, morbidity, and mortality[J]. Ann Surg, 2002, 236(3):355-366.
  • 2Bogoevski D, Yekebas EF, Schurr P, et al. Mode of spread in the early phase of lymphatic matastasis in pancreatic ductal adenocarci- noma: prognastic significance of nodal microinvolvement [J].Ann Surg, 2004,240(6):993-1000.
  • 3Matsuno S, Egawa S, Fukuyama S, in Japan: 20 years of experience[J]. et al. Pancreatic cancer registry Pancreas, 2004,28 (3):219-230.
  • 4金钢,胡先贵,刘瑞,张怡杰,邵成浩,唐岩.胰腺癌组织淋巴管分布及密度的临床病理学[J].中国医学科学院学报,2005,27(5):583-586. 被引量:12
  • 5Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma [,J]. Can- cer, 1996,77(5):858-863.
  • 6Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma[J]. J Natl Cancer lnst, 1992,84 (24) : 1875 - 1887.
  • 7Trojan L, Michel MS, Rensch F, et al. Lymph and blood vessel ar- chitecture in benign and malignant prostatic tissue: lack of lumphangiogenesis in prostate carcinoma assessed with novel lym- phatic maker lymphatic vessed endothelial hyalurman receptor (LYVE-1). J Urol, 2004,172( 1 ):103-107.
  • 8Ellis LM, Takahashi Y, Fenoglio C J, et al. Vessel counts and vascu- lar endothelial growth factor expression in pancreatic adenocarcino- ma[J]. Eur J cancer, 1998,334:337.
  • 9Fish W E, Berger DH. Angiogenesis and antian giogenic strategies in pancreatic cancer[J], lnt J Gastrointest Cancer, 2003,33 (1):79-88.
  • 10Seo Y, Baba H, Fukuda T, et al. High expression of vascular en- dothelial growth factor is associated with liver metastasis and a poor prognosis forpatients with ductal panereatic adenoeareinoma [J]. Caneer, 2000,88 ( 10):2239-2245.

二级参考文献39

  • 1Kayahara M, Nagakawa T, Kobayashi H, et al. Lymphatic flow in carcinoma of the head of the pancreas. Cancer,1992, 70(8):2061-2066.
  • 2Hosch SB, Knoefel WT, Metz S, et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas, 1997, 15(2):154-159.
  • 3Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg, 2002,236(3):355-366.
  • 4Matsuno S, Egawa S, Fukuyama S, et al. Pancreatic cancer registry in Japan: 20 years of experience. Pancreas, 2004,28(3):219-230.
  • 5Bogoevski D, Yekebas EF, Schurr P, et al. Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement. Ann Surg, 2004, 240(6):993-1000.
  • 6Sleeman JP, Krishnan J, Kirkin V, et al. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech, 2001, 55(2):61-69.
  • 7Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol, 1999, 22(4):789-801.
  • 8Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol, 1999, 154(2):385-394.
  • 9Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell, 1999,98(6):769-778.
  • 10Kahn HJ, Marks A. A new monoclonal antibody, D2-40,for detection of lymphatic invasion in primary tumors. Lab Invest, 2002, 82(9):1255-1257.

共引文献16

同被引文献15

  • 1Pandya NM, Dhalla NS, Santani DD, et al. Santani Angiogenesis a new target for futur therapy[J]. Vascular Pharmacology, 2006,44(5 ): 265-274.
  • 2Gupta GP, Massagu6 J. Cancer metastasis:building a framework [J]. Cell, 2006,127(4):679-695.
  • 3Weidner N, Carroll PR, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med, 1991,324( 1 ):1-4.
  • 4Li J, Tan H, Dong X, et al. Antisense integrin αV and β3 gene therapy suppresses subcutaneously implaanted hepatocellular carci- nomas[J]. Digestive and Liver Disease, 2007,39(6):557-565.
  • 5Hess-Stumpp H, Habereym, Thieranch KH. PTK787/ZK222584, a tyrosine kinase inhibitor of all known VEGF receptors,represses tu- mor growth with high efficacy[J]. Chembiochem, 2005,6(3):550- 557.
  • 6Chang YT, Chang MC, Wei SC, et al. Serum vascular endothelia growth factor/soluble vascular endothelial growth factor receptor-1 ratio is an independentprognosticmarker in pancreatic cancer[J]. Pancreas, 2008,37(2):145- 150.
  • 7Harper J, Yan L, Loureiro RM, et al. Repression of vascular en- dothelial growth factor expression by the zinc finger transcription factor ZNF24[J]. Cancer Res, 2007,67 ( 18 ):8736-8741.
  • 8Knowles J, Lozidou M, Taylor I. Endothelin-1 and angiogenesis in cancer[J]. Curr Vasc Pharmacol, 2005,3 (4):309-314.
  • 9Ochi N, Matsuo Y, Sawai H, et al. Vascular endothelial growth fae- tor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangio- genesis[J]. Pancreas, 2007,34(4):444-451.
  • 10Niedergethmann M, Hildenbrand R, Wostbrock B, et al. High ex- pression of vascular endothelial growth factor predicts early recur- rence and poor prognosis after curative resection for ductal adeno- carcinoma of the pancreas [J]. Pancreas, 2002,25 ( 2 ): 122-129.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部